환자 참여 솔루션 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제공별, 기능별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Patient Engagement Solutions Market Growth & Trends:

The global patient engagement solutions market size is estimated to reach USD 86.67 billion by 2030, registering to grow at a CAGR of 20.97% from 2025 to 2030 according to a new report by Grand View Research, Inc. Key factors fueling the market growth include rising digitalization across healthcare, increasing prevalence of chronic conditions, and technological advancements. COVID-19 pandemic boosted digitalization across healthcare. This, in turn, has fueled the awareness and adoption of patient engagement solutions, thus propelling the market growth.

As healthcare providers were battling the constant upsurge in cases, patients were looking to digital technologies for care delivery and monitoring. This contributed to the market growth. Key companies released multiple COVID-19-related features as part of their patient engagement lineup to enhance their offerings. In December 2020, athenahealth released new features to its athenaOne platform-such as scheduling, workflow, documentation, and reporting capabilities-to enable immediate administration of COVID-19 vaccines as and when they become available.

The necessity of social distancing resulted in increased demand for remote patient monitoring solutions and prerequisite for the precise and timely exchange of patient well-being records. Pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants have developed COVID-19-related features in their existing patient engagement solutions. For instance, in June 2020, Orion Health partnered with a network of more than 350 healthcare facilities called Keystone Health Information Exchange to enable real-time automated COVID-19 reporting for improved public health data collection across Pennsylvania and New Jersey.

As per a survey by Twilio, a cloud communications provider and customer engagement, 68% of respondents reported accelerated digitalization in their organizations due to COVID-19. Companies reported easing of barriers at organizational levels, such as getting executive approvals, the need for a clear strategy, and reluctance to replace legacy software. In fact, according to the Chief Product Officer at Mount Sinai Health System, their newly developed text?to?chat platform witnessed a 10x surge in volume due to the pandemic. Growing number of smartphone users around the globe expedited the adoption of digital health technologies across the sector, both from providers and consumers, which, in turn, has augmented the dependability of patients on mHealth apps.

Mobile technology has emerged as a pivotal driver of healthcare's digital and telemedicine revolution. Smartphones, tablets, and wearable devices have simplified access to healthcare support & patient records, elevated the quality of patient care, and streamlined back-office operations & medical training. Leveraging platforms such as WhatsApp for engagement enabled hospitals to manage patient interactions through an accessible communication channel. Solutions such as Easyrewardz Healthcare CRM empower hospital staff to automate patient communication, appointment scheduling, and room availability checks. These advancements are poised to fuel market growth over the forecast period.

Patient Engagement Solutions Market Report Highlights:

• The AI-driven engagement segment held the largest revenue share of 27.05% in 2024.
• Web/cloud-based held the largest revenue share of 72.27% in 2024 and is anticipated to expand at the fastest CAGR during the forecast period.
• The enhanced communication segment held the largest revenue share in 2024.
• The healthcare providers segment held the largest revenue share in 2024, driven by the increasing need to improve patient outcomes and streamline healthcare delivery.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.1.2. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type segment outlook
  • 2.2.2. Delivery segment outlook
  • 2.2.3. Functionality segment outlook
  • 2.2.4. End Use segment outlook
  • 2.2.5. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Patient Engagement Solutions Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Industry Analysis
  • 3.2.1. User Perspective Analysis
  • 3.2.2. Key End Users
• 3.3. Technology Outlook
• 3.4. Regulatory Framework
• 3.5. Market Dynamics
  • 3.5.1. Market Drivers Analysis
    • 3.5.1.1. Shift toward patient-centered care
    • 3.5.1.2. Growing need to curb rising healthcare costs
    • 3.5.1.3. Rising initiatives by organizations
    • 3.5.1.4. The emergence of digital platforms and necessity for omnichannel approach
  • 3.5.2. Market Restraints Analysis
    • 3.5.2.1. Data security and privacy concerns
  • 3.5.3. Industry Challenges and Opportunity Analysis
• 3.6. Patient Portal Market Analysis Tools
  • 3.6.1. PESTEL Analysis
    • 3.6.1.1. Political landscape
    • 3.6.1.2. Economic and Social landscape
    • 3.6.1.3. Technological landscape
    • 3.6.1.4. Environmental landscape
    • 3.6.1.5. Legal Landscape
  • 3.6.2. Porter's Five Forces Analysis:- Pharmacy
    • 3.6.2.1. Supplier power
    • 3.6.2.2. Buyer power
    • 3.6.2.3. Substitution threat
    • 3.6.2.4. Threat of new entrant
    • 3.6.2.5. Competitive rivalry
  • 3.6.3. Porter's five forces analysis :-Healthcare Payors
  • 3.6.4. Porter's five forces analysis :-Pharmaceutical Companies (Pharma)
  • 3.6.5. Porter's five forces analysis :-Healthcare Providers
• 3.7. Regulatory Framework
• 3.8. Case Studies & Insights
• 3.9. COVID-19 Impact Analysis

Chapter 4. Patient Engagement Solutions Market: Type Estimates & Trend Analysis

• 4.1. Patient Engagement Solutions Market: Type Movement Analysis
• 4.2. Patient Engagement Solutions Market: Type Segment Dashboard
• 4.3. Type Movement & Market Share Analysis, 2024 & 2030
• 4.4. Patient Engagement Solutions Market Estimates & Forecast, by Type
• 4.5. AI-Driven Engagement
  • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.6. Telehealth Solutions
  • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.7. Patient Portals
  • 4.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.8. Remote Patient Monitoring
  • 4.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.9. Population Health Management
  • 4.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.10. Appointment and Medication Reminders
  • 4.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 5. Patient Engagement Solutions Market: Delivery Estimates & Trend Analysis

• 5.1. Patient Engagement Solutions Market: Delivery Movement Analysis
• 5.2. Patient Engagement Solutions Market: Delivery Segment Dashboard
• 5.3. Delivery Movement & Market Share Analysis, 2024 & 2030
• 5.4. Patient Engagement Solutions Market Estimates & Forecast, by Delivery
• 5.5. Web/Cloud-Based
  • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 5.6. On-premise
  • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 6. Patient Engagement Solutions Market: Functionality Estimates & Trend Analysis

• 6.1. Patient Engagement Solutions Market: Functionality Movement Analysis
• 6.2. Patient Engagement Solutions Market: Functionality Segment Dashboard
• 6.3. Functionality Movement & Market Share Analysis, 2024 & 2030
• 6.4. Patient Engagement Solutions Market Estimates & Forecast, by Functionality
• 6.5. Enhanced Communication
  • 6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.6. Patient Education
  • 6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.7. Predictive Analysis
  • 6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.8. Streamlined Operations
  • 6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 7. Patient Engagement Solutions Market: End Use Estimates & Trend Analysis

• 7.1. Patient Engagement Solutions Market: End Use Movement Analysis
• 7.2. Patient Engagement Solutions Market: End Use Segment Dashboard
• 7.3. End Use Movement & Market Share Analysis, 2024 & 2030
• 7.4. Patient Engagement Solutions Market Estimates & Forecast, by End Use
• 7.5. Healthcare Providers
  • 7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.5.2. Outpatient Facility
    • 7.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Inpatient Facility
    • 7.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 7.6. Healthcare Payers
  • 7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.6.2. Private
    • 7.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Public
    • 7.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 7.7. Pharmaceutical Companies (Pharma)
  • 7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
• 7.8. Pharmacy
  • 7.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.2. Independent Pharmacies (Nuclear Pharmacies)
    • 7.8.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Community Pharmacies
    • 7.8.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.4. Mail-Order Pharmacies
    • 7.8.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.5. Retail Pharmacies
    • 7.8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.6. Digital Pharmacies
    • 7.8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.7. Specialty Pharmacies
    • 7.8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.8. Central Fill Pharmacies
    • 7.8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.9. Compounding Pharmacies
    • 7.8.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8.10. Others (Alternate dispensing site, Closed door)
    • 7.8.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 8. Patient Engagement Solutions Market: Regional Estimates & Trend Analysis by Region, Type, Delivery, Functionality, End Use

• 8.1. Definition and Scope
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Regional Market Dashboard
• 8.4. Regional Market Snapshot
• 8.5. SWOT Analysis
  • 8.5.1. North America
  • 8.5.2. Europe
  • 8.5.3. Asia Pacific
  • 8.5.4. Latin America
  • 8.5.5. Middle East & Africa
• 8.6. Patient Engagement Solutions Market Share, By Region, 2024 & 2030, USD Million
• 8.7. North America
  • 8.7.1. North America Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. U.S.
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Canada
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Canada Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. Mexico
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.7.4.3. Competitive Insights
    • 8.7.4.4. Canada Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Europe
  • 8.8.1. Europe Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. UK
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. UK Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Germany
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Germany Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. France
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. France Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Italy
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Italy Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.6. Spain
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.6.3. Competitive Insights
    • 8.8.6.4. Spain Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.7. Sweden
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.7.3. Competitive Insights
    • 8.8.7.4. Sweden Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.8. Denmark
    • 8.8.8.1. Key Country Dynamics
    • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.8.3. Competitive Insights
    • 8.8.8.4. Sweden Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.9. Norway
    • 8.8.9.1. Key Country Dynamics
    • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
    • 8.8.9.3. Competitive Insights
    • 8.8.9.4. Sweden Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.9. Asia Pacific
  • 8.9.1. Asia Pacific Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.2. China
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.2.3. Competitive Insights
    • 8.9.2.4. China Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.3. Japan
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.3.3. Competitive Insights
    • 8.9.3.4. Japan Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.4. India
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.4.3. Competitive Insights
    • 8.9.4.4. India Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.5. South Korea
    • 8.9.5.1. Key Country Dynamics
    • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.5.3. Competitive Insights
    • 8.9.5.4. South Korea Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.6. Australia
    • 8.9.6.1. Key Country Dynamics
    • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.6.3. Competitive Insights
    • 8.9.6.4. Australia Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.7. Thailand
    • 8.9.7.1. Key Country Dynamics
    • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
    • 8.9.7.3. Competitive Insights
    • 8.9.7.4. Thailand Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.10. Latin America
  • 8.10.1. Latin America Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.2. Brazil
    • 8.10.2.1. Key Country Dynamics
    • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.10.2.3. Competitive Insights
    • 8.10.2.4. Brazil Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10.3. Argentina
    • 8.10.3.1. Key Country Dynamics
    • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.10.3.3. Competitive Insights
    • 8.10.3.4. Argentina Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.11. Middle East and Africa
  • 8.11.1. Middle East and Africa Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.2. South Africa
    • 8.11.2.1. Key Country Dynamics
    • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.2.3. Competitive Insights
    • 8.11.2.4. South Africa Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.3. Saudi Arabia
    • 8.11.3.1. Key Country Dynamics
    • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.3.3. Competitive Insights
    • 8.11.3.4. Saudi Arabia Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.4. UAE
    • 8.11.4.1. Key Country Dynamics
    • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.4.3. Competitive Insights
    • 8.11.4.4. UAE Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11.5. Kuwait
    • 8.11.5.1. Key Country Dynamics
    • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
    • 8.11.5.3. Competitive Insights
    • 8.11.5.4. Kuwait Patient Engagement Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share/Position Analysis, 2024
• 9.4. Company Heat Map Analysis
• 9.5. Company Profiles
  • 9.5.1. Cerner Corporation (Oracle)
    • 9.5.1.1. Participant's Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. NextGen Healthcare, Inc.
    • 9.5.2.1. Participant's Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Epic Systems Corporation
    • 9.5.3.1. Participant's Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. Allscripts Healthcare, LLC
    • 9.5.4.1. Participant's Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. McKesson Corporation
    • 9.5.5.1. Participant's Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. ResMed
    • 9.5.6.1. Participant's Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. Koninklijke Philips N.V.
    • 9.5.7.1. Participant's Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. Klara Technologies, Inc.
    • 9.5.8.1. Participant's Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. CPSI, Ltd.
    • 9.5.9.1. Participant's Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives
  • 9.5.10. Experian Information Solutions, Inc.
    • 9.5.10.1. Participant's Overview
    • 9.5.10.2. Financial Performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic Initiatives
  • 9.5.11. athenahealth
    • 9.5.11.1. Participant's Overview
    • 9.5.11.2. Financial Performance
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic Initiatives
  • 9.5.12. Solutionreach, Inc.
    • 9.5.12.1. Participant's Overview
    • 9.5.12.2. Financial Performance
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic Initiatives
  • 9.5.13. IBM
    • 9.5.13.1. Participant's Overview
    • 9.5.13.2. Financial Performance
    • 9.5.13.3. Product Benchmarking
    • 9.5.13.4. Strategic Initiatives
  • 9.5.14. MEDHOST
    • 9.5.14.1. Participant's Overview
    • 9.5.14.2. Financial Performance
    • 9.5.14.3. Product Benchmarking
    • 9.5.14.4. Strategic Initiatives
  • 9.5.15. Nuance Communications, Inc.
    • 9.5.15.1. Participant's Overview
    • 9.5.15.2. Financial Performance
    • 9.5.15.3. Product Benchmarking
    • 9.5.15.4. Strategic Initiatives